Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated a 15% average body weight reduction in clinical trials when used for weight management. Many patients wonder how to properly prepare their injections, but PlexusDx simplifies this process by delivering fully reconstituted compounds from licensed compounding pharmacies, requiring no mixing or preparation on your part.
What Does Semaglutide Reconstitution Actually Mean?
Reconstitution refers to the process of mixing a dry powder medication with a liquid solution to create an injectable form. In traditional pharmacy settings, semaglutide powder arrives in vials and must be combined with a sterile diluent before use. This process demands precise measurements, sterile technique, and proper storage conditions to maintain medication safety and effectiveness. The reconstituted solution becomes unstable over time, making storage and timing critical factors for patients managing the process themselves.
PlexusDx eliminates this complexity entirely by partnering with licensed 503A compounding pharmacies that handle all reconstitution before your medication arrives at your door. Your semaglutide injection is ready to use immediately upon delivery, with proper sterility verification and stability testing already completed by pharmacy professionals. This approach removes potential errors from manual mixing and ensures consistent, safe dosing with every injection you administer.
Why Licensed 503A Pharmacies Handle Reconstitution Better
Licensed 503A compounding pharmacies operate under strict federal regulations and state pharmacy board oversight, ensuring every batch meets pharmaceutical-grade standards. These facilities maintain temperature-controlled environments, use validated equipment for precise measurements, and perform sterility testing on finished compounds before distribution. The difference between patient-prepared reconstitution and pharmacy-prepared compounds lies in consistency, safety verification, and compliance documentation—advantages that directly impact treatment outcomes and your confidence in medication quality.
PlexusDx sources semaglutide from 503A compounding pharmacies exclusively, never 503B facilities, because 503A pharmacies operate under direct pharmacist supervision and individualized patient care protocols. Each dose is prepared according to your specific prescription, labeled with expiration dating based on stability data, and shipped with proper cold-chain handling. This professional preparation means you skip the mixing step entirely and focus only on administering your weekly injection as directed by your provider.
The Injection Schedule and Storage Considerations
Once semaglutide is reconstituted—whether by a pharmacy or at home—the timeline for use becomes critical. Compounded semaglutide injections typically remain stable for 28 days when stored at 2–8°C (refrigerator temperature), though exact stability depends on formulation specifics provided by your compounding pharmacy. PlexusDx patients receive pre-reconstituted injections with clear expiration dating and storage instructions, eliminating guesswork about whether their medication remains safe to use. Your pharmacy provides specific guidance based on your particular compound's stability profile, determined during the reconstitution and testing process.
Weekly injection timing follows a standard protocol: one injection per week on the same day each week, injected subcutaneously into the abdomen, thigh, or upper arm. Patients typically begin with a lower dose and gradually increase over several weeks based on tolerance and weight loss response. PlexusDx providers manage your dose progression and monitoring throughout treatment, ensuring your injections remain effective while minimizing side effects. Proper storage—keeping your pens or syringes refrigerated until use—maintains medication stability and safety through your full treatment course.
How PlexusDx Pricing Keeps Reconstituted Semaglutide Affordable
PlexusDx compounded semaglutide injections start at $149 per month across all dose levels, with a straightforward pricing model that doesn't increase as your dose escalates. This flat-rate approach means your dose may need to go up as your body adjusts to treatment, but your price won't—a key difference from traditional pharmacy models that charge per unit or per dose strength. No insurance is required, no membership fees apply, and the medication is HSA/FSA eligible, making premium-quality compounded semaglutide accessible regardless of your insurance status.
The cost of $149 monthly covers fully reconstituted, ready-to-inject semaglutide prepared by licensed 503A pharmacies and delivered nationwide across all 50 states. Patients avoid hidden fees, surprise increases at higher doses, or mandatory annual memberships that other weight loss services require. PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after first month) to identify which GLP-1 pathway variants may affect your individual response, helping your provider optimize your treatment plan from the start.
Personalization Through Genetic Testing for Optimal Results
PlexusDx's Precision Peptide Genetic Test analyzes your genetic variants in 14 metabolic pathways across 49 peptides, identifying genetic predictors of GLP-1 receptor function, appetite regulation, and weight loss potential. Key variants like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 influence how your body responds to semaglutide specifically. By mapping these genetic insights before or early in your treatment, your PlexusDx provider gains clarity about which GLP-1 compounds and dosing strategies align best with your genetics, increasing the likelihood of meaningful weight loss and tolerability.
Genetic testing isn't pharmacogenomic (predicting drug metabolism) but rather peptide-pathway focused, revealing whether your appetite-regulating biology naturally favors GLP-1 response, dual-pathway therapy, or alternative approaches. Patients with specific genetic profiles may experience faster weight loss on semaglutide, while others may benefit from PlexusDx's combination products like GLP-Squared (semaglutide plus tirzepatide injected together). This personalized approach transforms reconstituted semaglutide from a standard treatment into a therapy tailored to your unique metabolic genetics.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I have to mix my own semaglutide powder at home?
No. PlexusDx delivers fully reconstituted semaglutide injections ready to use immediately upon arrival. Licensed 503A compounding pharmacies handle all mixing, sterility verification, and preparation before your medication ships, so you only need to refrigerate it and inject weekly as directed.
What clinical evidence supports semaglutide for weight loss?
Phase 3 trials demonstrated average weight loss of 15% when semaglutide was used specifically for weight management, compared to placebo.
Why does PlexusDx only use 503A compounding pharmacies?
503A pharmacies operate under state pharmacy board regulation and direct pharmacist oversight for individualized patient prescriptions, unlike 503B facilities that prepare bulk compounds.
How long does reconstituted semaglutide stay safe to use?
Compounded semaglutide typically remains stable for 28 days when refrigerated at 2–8°C, though your specific pharmacy provides exact expiration dating based on their formulation. PlexusDx compounds arrive labeled with clear expiration information, and your provider advises you on proper storage and usage windows.
Can genetic testing predict how well I'll respond to semaglutide?
Yes. PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and GLP-1 pathway sensitivity.
What does PlexusDx's $149 monthly price include?
The $149 flat monthly rate covers fully reconstituted, pharmacy-prepared semaglutide injections ready to use, delivered nationwide with no insurance required and no flat per-compound pricing increases. HSA/FSA coverage applies, and no membership fees or hidden charges exist.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Often Do You Take GLP-1 Medications for Weight Loss?
How Long Do Side Effects Last After Semaglutide Injection?